(Q40593461)

21 September 2017

title

Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment (English)

1 reference

21 September 2017

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment (English)

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

25 December 2023

0 references

0 references

interstitial lung disease

1 reference

based on heuristic

inferred from title

Anesthesiology and pain medicine

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

25 December 2023

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

25 December 2023

author name string

Armin Schnabel

1

1 reference

21 September 2017

Michael Reuter

2

1 reference

21 September 2017

Jürgen Biederer

3

1 reference

21 September 2017

Christiane Richter

4

1 reference

21 September 2017

Wolfgang L. Gross

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12701038

25 December 2023

language of work or name

1 reference

1 April 2003

1 reference

full work available at URL

21 September 2017

https://api.elsevier.com/content/article/PII:S0049017202701200?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

https://api.elsevier.com/content/article/PII:S0049017202701200?httpAccept=text/plain

25 December 2023

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Seminars in Arthritis and Rheumatism

25 December 2023

published in

1 reference

21 September 2017

volume

32

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

273-284

1 reference

Pulmonary disease in polymyositis/dermatomyositis

21 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

25 December 2023

2

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Interstitial lung disease in dermatomyositis: clinicopathological study

25 December 2023

3

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis

25 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings

25 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis

25 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement

25 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Pulmonary involvement in polymyositis and in dermatomyositis

25 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

25 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis

25 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

25 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis

25 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Polymyositis and dermatomyositis (first of two parts)

25 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

High resolution computed tomography as a predictor of lung histology in systemic sclerosis

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis

25 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography

25 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

25 December 2023

21

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Fibrosing alveolitis: CT-pathologic correlation

25 December 2023

23

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT

25 December 2023

24

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography.

25 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases

25 December 2023

26

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

25 December 2023

27

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung

25 December 2023

28

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

25 December 2023

29

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

25 December 2023

30

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography

25 December 2023

31

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis

25 December 2023

32

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

Cyclophosphamide for the treatment of systemic lupus erythematosus

25 December 2023

33

1 reference

https://api.crossref.org/works/10.1053/SARH.2002.50012

25 December 2023

Identifiers

1 reference

21 September 2017

1 reference